Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted Biopsy

Marc A. Bjurlin, Samir S. Taneja

Research output: Contribution to journalReview articlepeer-review

Abstract

Prostate MRI is commonly used in the detection of prostate cancer to reduce the detection of clinically insignificant disease; maximize the detection of clinically significant cancer; and better assess disease size, grade, and location. The clinical utility of MRI seems to apply to men with no prior biopsy, who have had a previous negative biopsy, and men who are candidate for active surveillance. In conjunction with traditional clinical parameters and secondary biomarkers, MRI may allow more accurate risk stratification and assessment of need for prostate biopsy.

Original languageEnglish (US)
Pages (from-to)535-546
Number of pages12
JournalUrologic Clinics of North America
Volume44
Issue number4
DOIs
StatePublished - Nov 2017

Keywords

  • MRI
  • MRI-ultrasonography fusion
  • Prebiopsy
  • Risk assessment
  • Targeted biopsy

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted Biopsy'. Together they form a unique fingerprint.

Cite this